$BOLD Audentes Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Audentes Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Audentes Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Audentes Therapeutics, Inc. for free.

CIK Number: 0001628738
IRS Number: 461606174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BOLD
Company Address: 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO 94108
Phone number: 415-638-6556

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.

Market Capitalization: $337.82M
Prev close: $15.83
Average Daily Volume: 57,173
Days Low: $15.30
Year Low: $13.06
Year High: $20.74

Audentes Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Goldberg Mark AlanDirector00Feb 08 20193 months ago
Holles Natalie C.President and COO56,723897,925shares bought: 56,723 / shares sold: 0 STRONG BUYFeb 08 20193 months ago
Jarrett JenniferDirector00Feb 08 20193 months ago
LANGE LOUIS GDirector306,0994,845,547shares bought: 24,633 / shares sold: -286,558 STRONG SELLMar 27 201930 days ago
Meltz Mark ASVP, General Counsel37,333590,981shares bought: 37,333 / shares sold: 0 BUYApr 01 201925 days ago
Morrison Scott WDirector00Feb 08 20193 months ago
Patterson Matthew RChief Executive Officer135,7002,148,131shares bought: 285,700 / shares sold: -197,000 BUYFeb 27 20192 months ago
PRASAD SUYASHSenior VP & Chief Med Officer28,236446,976shares bought: 74,236 / shares sold: -56,000 BUYFeb 27 20192 months ago
Schuetz Thomas J.Director00Feb 08 20193 months ago
Smith JulieDirector00Feb 08 20193 months ago
Soloway Thomas PExecutive Vice President, CFO23,333369,361shares bought: 23,333 / shares sold: 0 BUYFeb 08 20193 months ago

View all Audentes Therapeutics, Inc. insiders.

Audentes Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 01 2019BOLDAudentes Therapeut ...Meltz Mark ASVP, General Counse ...Option ExerciseA37.26104,0003,875,040104,000
Apr 01 2019BOLDAudentes Therapeut ...Meltz Mark ASVP, General Counse ...GrantA0.0037,333037,3330 to 37.3 K
Mar 27 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS35.9455820,0550558 to 0 (-100.00 %)
Mar 27 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS36.001,00036,00416,67817.7 K to 16.7 K (-5.66 %)
Mar 27 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS36.6430010,992305,799306.1 K to 305.8 K (-0.10 %)
Mar 27 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS35.9919,700709,023306,099325.8 K to 306.1 K (-6.05 %)
Feb 27 2019BOLDAudentes Therapeut ...PRASAD SUYASHSenior VP & Chief M ...Option ExerciseM0.7910,0007,90040,870
Feb 27 2019BOLDAudentes Therapeut ...PRASAD SUYASHSenior VP & Chief M ...SellS30.0610,000300,55318,23628.2 K to 18.2 K (-35.42 %)
Feb 27 2019BOLDAudentes Therapeut ...PRASAD SUYASHSenior VP & Chief M ...BuyM0.7910,0007,90028,23618.2 K to 28.2 K (+54.84 %)
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...Option ExerciseM2.194,0008,76074,297
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...Option ExerciseM0.7817,00013,26064,751
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...SellS30.004,000120,000118,700122.7 K to 118.7 K (-3.26 %)
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...BuyM2.194,0008,760122,700118.7 K to 122.7 K (+3.37 %)
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...SellS30.0017,000510,000118,700135.7 K to 118.7 K (-12.53 %)
Feb 27 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...BuyM0.7817,00013,260135,700118.7 K to 135.7 K (+14.32 %)

View all Audentes Therapeutics, Inc. insider transactions.